... disclosing disappointing clinical trial results for the drug bapineuzumab (AAB-001) ("bapi"). Bapi was an Alzheimer's disease treatment that was being jointly developed by Wyeth and Elan Corporation, plc. On June 17, 2008 Wyeth released top-line ...
http://eon.businesswire.com/news/eon/20130415006704/en/Law-Offices-Howard-G.-Smith-Announces-Investigation
http://eon.businesswire.com/news/eon/20130415006704/en/Law-Offices-Howard-G.-Smith-Announces-Investigation
No comments:
Post a Comment